# Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer

> **NCT00003175** · PHASE2 · COMPLETED · sponsor: **Medical Research Council** · enrollment: 45 (estimated)

## Conditions studied

- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
- Urethral Cancer

## Interventions

- **DRUG:** fluorouracil

## Key facts

- **NCT ID:** NCT00003175
- **Lead sponsor:** Medical Research Council
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-12
- **Primary completion:** —
- **Final completion:** 2009-03
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2013-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003175, "Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*